RBM Platform Potential Remarque Systems specializes in a real-time, end-to-end RBM capable platform for clinical trials. This indicates opportunities to upsell advanced monitoring and analytics features to life sciences firms seeking integrated data management and risk assessment across sites.

Growth and Scale With a small team (11-50 employees) and revenue in the 10-25M range, Remarque may be pursuing scalable, cloud-based solutions and partnerships to support rapid growth. This presents chances to offer managed services, implementation support, and partner-led go-to-market strategies.

Tech Stack Fit The current tech stack includes cloud and data visualization tools (Google Cloud, WordPress, Google Tag Manager, Bootstrap, Adobe Suite). This suggests receptiveness to integrations with enterprise data sources, BI dashboards, and compliant data pipelines that can be offered as add-on connectors and enterprise-grade integrations.

Clinical Trial Focus Emphasis on consolidating disparate trial data and providing risk-based monitoring signals positions Remarque to pursue cross-functional data governance, compliance automation, and interoperability services with CROs and biopharma sponsors seeking efficiency gains.

Recent Milestone Signals The 2018 RBM v2018.1 Dashboard Viewer release signals a product development cadence and customer-centric updates. Sales opportunity exists in highlighting ongoing roadmap, renewals, and expansion of RBM capabilities to new therapeutic areas or larger studies.